TD Private Client Wealth LLC Buys 144 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

TD Private Client Wealth LLC raised its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 342.9% in the third quarter, HoldingsChannel reports. The fund owned 186 shares of the medical instruments supplier’s stock after acquiring an additional 144 shares during the period. TD Private Client Wealth LLC’s holdings in Mettler-Toledo International were worth $279,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in MTD. State Street Corp boosted its stake in Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after purchasing an additional 9,009 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Mettler-Toledo International by 0.8% during the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after buying an additional 4,166 shares in the last quarter. Barclays PLC boosted its position in shares of Mettler-Toledo International by 8.3% in the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after acquiring an additional 19,609 shares during the period. Loomis Sayles & Co. L P grew its stake in shares of Mettler-Toledo International by 1.8% in the third quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock valued at $314,790,000 after acquiring an additional 3,644 shares in the last quarter. Finally, Wellington Management Group LLP increased its position in Mettler-Toledo International by 17.5% during the third quarter. Wellington Management Group LLP now owns 177,963 shares of the medical instruments supplier’s stock worth $266,891,000 after acquiring an additional 26,443 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insiders Place Their Bets

In related news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares in the company, valued at $7,524.54. The trade was a 95.89 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. The trade was a 24.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Up 0.0 %

NYSE:MTD opened at $1,276.98 on Friday. Mettler-Toledo International Inc. has a twelve month low of $1,115.64 and a twelve month high of $1,546.93. The stock’s 50-day simple moving average is $1,305.85 and its 200 day simple moving average is $1,376.86. The firm has a market capitalization of $26.95 billion, a PE ratio of 34.43, a price-to-earnings-growth ratio of 4.19 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Stifel Nicolaus decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company reduced their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their target price for the stock from $1,200.00 to $1,300.00 in a report on Wednesday. Finally, Evercore ISI raised their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.